| dc.contributor | 法學院 | |
| dc.creator (作者) | 魏杏芳 | |
| dc.date (日期) | 2023-04 | |
| dc.date.accessioned | 2024-12-12 | - |
| dc.date.available | 2024-12-12 | - |
| dc.date.issued (上傳時間) | 2024-12-12 | - |
| dc.identifier.uri (URI) | https://nccur.lib.nccu.edu.tw/handle/140.119/154602 | - |
| dc.format.extent | 130 bytes | - |
| dc.format.mimetype | text/html | - |
| dc.relation (關聯) | 醫藥、科技與法律, Vol.28, No.1, pp.1-40 | |
| dc.subject (關鍵詞) | 標示外使用; Avastin/Lucentis案; 目的限制競爭; 集體支配地位; 貶抑行為 | |
| dc.subject (關鍵詞) | Off-label use; Avastin/Lucentis case; Restriction of competition by object; Collective dominance; Disparagement practice | |
| dc.title (題名) | 由競爭法觀點談「藥品標示外使用」—以歐盟Avastin/Lucentis案為中心 | |
| dc.title (題名) | Competition Law Perspectives on Off-Label Drug Use--The EU Avastin/Lucentis Case Study and Its Implications | |
| dc.type (資料類型) | article | |
